Canaloplasty and trabeculotomy using the Omni Surgical System (Sight Sciences), and performed in conjunction with cataract surgery, significantly reduced unmedicated mean diurnal IOP, medication use, and daily fluctuations in IOP in patients with open-angle glaucoma, researchers with the GEMINI study group recently reported. The 12-month data were published in Clinical Ophthalmology.1 Mean unmedicated diurnal IOP reduction in the GEMINI study was 35% (23.8 mmHg to 15.6 mmHg) and a medication reduction of 80% (1.8 to 0.4). Additionally, 84.2% of eyes had IOP reductions of more than 20% from baseline, 80% of eyes were medication-free, and 76% of eyes achieved an IOP of 6 mmHg to 18 mmHg.
“We now have 12 months of prospective, multicenter data showing 360° canaloplasty and 180° trabeculotomy performed with the Omni Surgical System at the time of cataract surgery significantly reduced unmedicated mean diurnal IOP and medication use at 12 months postoperatively,” said investigator Mark J. Gallardo, MD, of El Paso Eye Surgeons in a news release. “This conclusion was also observed in the Hispanic population, where there’s increased prevalence of glaucoma with a higher proportion who are undiagnosed.”
Reference
- MJ, Pyfer MF, Vold SD, et al. Canaloplasty and trabeculotomy combined with phacoemulsification for glaucoma: 12-month results of the GEMINI study. Clin Ophthalmol. 2022;16:1225-1234. doi:10.2147/OPTH.S362932
